Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Eylea 40 mg/ml solution for injection in pre-filled syringe

Active Ingredient:
aflibercept
Company:  
Bayer plc See contact details
ATC code: 
S01LA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video
{arrow_left}
{arrow_right}
EYLEA WAMD Patient Guide - Audio Version

Your guide to Eylea - for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Reference: PP-EYL-GB-2763

EYLEA DMO Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to diabetic macular oedema (DMO)

Reference: PP-EYL-GB-2765

EYLEA BRVO Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO)

Reference: PP-EYL-GB-2764

EYLEA CRVO Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO)

Reference: PP-EYL-GB-2766

EYLEA CNV Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to myopic choroidal neovascularisation(myopic CNV)

Reference: PP-EYL-GB-2762

EYLEA Prescriber Guide

Intravitreal injection procedure video intended for Healthcare Professionals

Reference: PP-EYL-GB-2586

Bayer plc
Company image
Address
400 South Oak Way, Reading, Berkshire, RG2 6AD
Medical Information e-mail
[email protected]
WWW
http://www.bayer.co.uk
Telephone
+44 (0)118 206 3000